Fibrosis is a common outcome in chronic liver disease, with progression to cirrhosis accounting for thousands of deaths each year. Siemens offers the ELF™ test* which aids physicians in the diagnosis of fibrosis in the patient’s liver.
ELF Assays & Reagents
- Hyaluronic acid (HA)
- Procollagen III amino terminal peptide (PIIINP)
- Tissue inhibitor of metalloproteinase 1 (TIMP-1)
What is Liver Fibrosis?
Non-Invasive markers of liver fibrosis
The ELF Program
Educational Webinar: Chronic Liver Disease and the Clinical Case for the Enhanced Liver Fibrosis (ELF™) Test
* Availability may vary depending on regulatory requirements.